Autologous Bone Marrow Transplantation for Acute Non-Lymphoblastic Leukemia During First or Subsequent Remission
Evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation for AML.
Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.
- procedure : high dose chemotherapy then autologous hematopoietic cell transplant
Phase: Phase 2
Ages Eligible For Study:
- must be in remission - adequate organ function